Analysis of the paired primary and metastatic tumours of 17 patients who had paired metachronous metastatic tumours showed a significant correlation between MSLN expression in primary and metastatic lesions (Spearman’s rank correlation coefficient; Rs = 0.557, p = 0.015, Fig. 3). Here, MSLN is linked to metastatic neoplasm.